Skip to content
Open access

Associations of rheumatoid arthritis, chronic lung diseases, and acute respiratory exacerbations among people who smoke in the prospective COPDGene study.

Sep 2026 · Seminars in Arthritis & Rheumatism · Vol 81, pp. 153080 · 0 citations · 45 references
Medicine

TL;DR

In this large prospective study, people who smoke with RA were more likely to have ILA and BR than those without RA, but had similar prevalences of COPD and MP.

Abstract

Objective

To investigate associations between rheumatoid arthritis (RA), chronic lung diseases, and acute respiratory exacerbations.

Methods

Using the multicenter prospective COPDGene cohort of people who smoke (currently or previously), RA cases were identified using self-report and disease-modifying antirheumatic drug use. Interstitial lung abnormalities (ILA), bronchiectasis (BR), chronic obstructive pulmonary disease (COPD), and mucus plugging (MP) were identified via high-resolution computed tomography scans and spirometry and prevalences were compared among participants with and without RA. Risk of acute respiratory exacerbation over 10 years of follow-up was compared for those with and without RA and stratified by lung abnormality using multivariable Cox regression, accounting for competing mortality risk.

Results

We analyzed 76 RA cases (mean age 64.0 years, 67.1% female) and 8175 non-RA comparators (mean age 59.4 years, 46.2% female). RA cases vs non-RA comparators had higher prevalences of ILA (17.3%vs 7.1%, p = 0.0002) and BR (35.5%vs 24.6%, p = 0.027), but prevalences of COPD (46.1%vs 43.7%, p = 0.69) and MP (36.8%vs 29.6%, p = 0.17) were similar. RA was associated with higher risk of acute respiratory exacerbation than non-RA (adjusted HR 1.68, 95%CI 1.25 to 2.26), and those with RA and COPD had the highest risk (adjusted HR 3.57, 95%CI 2.15 to 5.94) compared to non-RA without COPD.

Conclusion

In this large prospective study, people who smoke with RA were more likely to have ILA and BR than those without RA, but had similar prevalences of COPD and MP. Participants with RA, particularly those with COPD, had higher risk of acute respiratory exacerbation.

Read PDF

Similar papers

Open access Sep 2026

Multidimensional Inflammatory Biomarker Profiling in COPD: A Latent Inflammatory Construct Associated with Disease Severity and Exacerbation Burden

Background/Objectives: Systemic inflammation is a widely recognised feature of chronic obstructive pulmonary disease (COPD). The combined contribution of acute-phase reactants and pro-inflammatory cytokines to disease severity and exacerbation risk remains incompletely understood. This study evaluated the associations...

Oana Maria Catană, Ramona Cioboată, D. Mitroi et al. · 0 citations
Sep 2026

Systemic Platelet Activation and Respiratory Exacerbations, Pulmonary Symptoms, and Mortality among Current and Former Smokers in SPIROMICS.

RATIONALE Platelet activation is elevated in chronic obstructive pulmonary disease (COPD) and associated with self-reported respiratory symptoms. Observational studies link the antiplatelet drug aspirin to lower exacerbation rates and fewer symptoms. However, it is unknown if platelet activation predicts incident respi...

A. Fawzy, N. Hansel, N. Putcha et al. · 0 citations
Open access Oct 2026

Identifying fibrotic interstitial lung disease risk in COPD, asthma and heart failure

Fibrotic interstitial lung disease (fILD) is often diagnosed late and can be difficult to recognise in people with common respiratory or cardiac long-term conditions. We examined whether baseline routine blood-test profiles and leucocyte telomere length (LTL) identified groups at higher risk of subsequent hospital-...

G. Lough, L. Wain, A. Meffen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.